Skip to content

Clinical trials

Completed Non-alcoholic Fatty Liver Disease trials in Australia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Non-alcoholic Fatty Liver Disease Status: Completed Country / region: Australia Clear all

28 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20142
20151
20161
20174
20181
20191
20206
20218
20222
20231
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed28

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Altimmune, Inc.3
NGM Biopharmaceuticals, Inc3
Gilead Sciences2
Merck Sharp & Dohme LLC2
Novo Nordisk A/S2
AstraZeneca1
Bird Rock Bio, Inc.1
Blade Therapeutics1
Boehringer Ingelheim1
Dongguan HEC Biopharmaceutical R&D Co., Ltd.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Non-alcoholic Fatty Liver Disease28
Obesity3
Digestive System Diseases2
Arthritis, Rheumatoid1
Diabetes Mellitus, Type 21
Fatty Liver1
Fibrosis1
Liver Cirrhosis1
Liver Diseases1
Osteoarthritis1

Trials

Showing 1 to 25 of 28. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.